Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.6 USD | -0.10% | +2.89% | +4.35% |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 1,240 | 578.9 | 264.8 | 501.9 | 647.9 | - | - |
Enterprise Value (EV) 1 | 1,240 | 578.9 | 264.8 | 266.8 | 647.9 | 647.9 | 647.9 |
P/E ratio | -10.1 x | -7.1 x | -2.62 x | -4.69 x | -5.57 x | -4.99 x | -4.72 x |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - | 27.5 x |
EV / Revenue | - | - | - | - | - | - | 27.5 x |
EV / EBITDA | -16.9 x | -7.42 x | -2.92 x | -4.57 x | -5.44 x | -5.11 x | -5.98 x |
EV / FCF | -27 x | -9.57 x | -3.43 x | -5.8 x | -8.31 x | -6 x | -4.35 x |
FCF Yield | -3.7% | -10.4% | -29.2% | -17.2% | -12% | -16.7% | -23% |
Price to Book | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 36,634 | 39,382 | 44,953 | 54,552 | 67,422 | - | - |
Reference price 2 | 33.85 | 14.70 | 5.890 | 9.200 | 9.610 | 9.610 | 9.610 |
Announcement Date | 21-03-23 | 22-03-21 | 23-03-16 | 24-03-11 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | 23.55 |
EBITDA 1 | - | -73.22 | -77.97 | -90.8 | -109.7 | -119 | -126.8 | -108.4 |
EBIT 1 | -28.57 | -74.19 | -78.87 | -91.77 | -110.8 | -124.9 | -146.6 | -163.9 |
Operating Margin | - | - | - | - | - | - | - | -696.19% |
Earnings before Tax (EBT) 1 | - | -73.7 | -78.72 | -89.12 | -100.7 | -113.9 | -139.8 | -155.8 |
Net income 1 | - | -73.7 | -78.72 | -89.12 | -100.7 | -113.8 | -139.1 | -155.8 |
Net margin | - | - | - | - | - | - | - | -661.73% |
EPS 2 | - | -3.360 | -2.070 | -2.250 | -1.960 | -1.724 | -1.926 | -2.036 |
Free Cash Flow 1 | - | -45.94 | -60.48 | -77.22 | -86.54 | -78 | -108 | -149 |
FCF margin | - | - | - | - | - | - | - | -632.81% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share 2 | - | - | - | - | - | - | - | - |
Announcement Date | 20-02-28 | 21-03-23 | 22-03-21 | 23-03-16 | 24-03-11 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA 1 | - | - | - | - | -21.87 | -25.42 | -24.73 | -28.42 | -31.16 | -28.73 | -29.51 | -30.09 | -30.69 | - | - |
EBIT 1 | -22.8 | -23.26 | -20.7 | -25.69 | -22.12 | -25.68 | -24.99 | -28.68 | -31.43 | -28.99 | -30.55 | -31.99 | -33.23 | -33.66 | -34.48 |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -22.77 | -23.16 | -20.29 | -24.83 | -20.85 | -23.94 | -22.94 | -25.48 | -28.33 | -25.01 | -27.72 | -29.67 | -31.39 | -32.8 | -33.5 |
Net income 1 | -22.77 | -23.16 | -20.29 | -24.83 | -20.85 | -23.94 | -22.94 | -25.48 | -28.33 | -25.01 | -27.81 | -29.64 | -31.26 | -32.22 | -33.18 |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -0.5800 | -0.5900 | -0.5100 | -0.6300 | -0.5200 | -0.5300 | -0.5000 | -0.4400 | -0.4900 | -0.3700 | -0.4122 | -0.4347 | -0.4572 | -0.4800 | -0.4933 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 22-03-21 | 22-05-09 | 22-08-11 | 22-11-07 | 23-03-16 | 23-05-08 | 23-08-10 | 23-11-06 | 24-03-11 | 24-05-06 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - |
Net Cash position | - | - | - | 235 | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow 1 | -45.9 | -60.5 | -77.2 | -86.5 | -78 | -108 | -149 |
ROE (net income / shareholders' equity) | -39% | -28% | -36% | -45.1% | -50% | -44.7% | -34.2% |
ROA (Net income/ Total Assets) | -37.5% | -26.3% | -32.7% | -40.3% | -44.9% | -40.2% | - |
Assets 1 | 196.5 | 298.8 | 272.9 | 249.6 | 253.8 | 346 | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex 1 | 0.67 | 0.94 | 2.08 | 0.85 | - | 0.5 | 1 |
Capex / Sales | - | - | - | - | - | - | 4.25% |
Announcement Date | 21-03-23 | 22-03-21 | 23-03-16 | 24-03-11 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.35% | 648M | |
+2.93% | 106B | |
+7.02% | 23.47B | |
-14.60% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.83% | 16.78B | |
+5.51% | 14.41B | |
+37.49% | 12.86B | |
+329.39% | 8.78B |
- Stock Market
- Equities
- ORIC Stock
- Financials ORIC Pharmaceuticals, Inc.